Location History:
- Dohren, DE (1989)
- Gross Dohren, DE (1989)
Company Filing History:
Years Active: 1989
Title: The Innovative Contributions of Sabine Breiding-Mack
Introduction
Sabine Breiding-Mack is a notable inventor based in Dohren, Germany. She has made significant contributions to the field of pharmacology, particularly through her innovative research and development of novel compounds. With a total of 2 patents, her work has implications for antifungal, antiviral, and antibacterial applications.
Latest Patents
Her latest patents include the pharmacological use of phenoxazinones, which are derived from the bacterium Streptomyces spec. DSM 3813. These compounds exhibit antifungal and antiviral actions and can serve as lipoxygenase inhibitors. Another significant patent involves gentisic acid derivatives, specifically 2-acetylaminogentisic acid, which has been isolated from the culture broth of Streptomyces. This compound demonstrates antibacterial activity against both Gram-positive and Gram-negative bacteria.
Career Highlights
Sabine Breiding-Mack is associated with Hoechst Aktiengesellschaft, where she has been able to apply her expertise in pharmacology. Her work has not only advanced scientific understanding but also contributed to the development of potential therapeutic agents.
Collaborations
Throughout her career, she has collaborated with esteemed colleagues such as Axel Zeeck and Susanne Grabley, enhancing the impact of her research through teamwork and shared knowledge.
Conclusion
Sabine Breiding-Mack's innovative work in pharmacology exemplifies the importance of research in developing new therapeutic agents. Her contributions continue to influence the field and pave the way for future advancements.